title: BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
authors.affiliation: Rheumatology Department, University Hospitals of Morecambe Bay NHS Foundation Trust, Royal Lancaster Infirmary, Lancaster LA1 4RP, UK. marwan.bukhari@mbht.nhs.uk
authors.forename: Marwan
authors.initials: M
authors.lastname: Bukhari
authors.forename: Rikki
authors.initials: R
authors.lastname: Abernethy
authors.forename: Chris
authors.initials: C
authors.lastname: Deighton
authors.forename: Tina
authors.initials: T
authors.lastname: Ding
authors.forename: Kimme
authors.initials: K
authors.lastname: Hyrich
authors.forename: Mark
authors.initials: M
authors.lastname: Lunt
authors.forename: Raashid
authors.initials: R
authors.lastname: Luqmani
authors.forename: Patrick
authors.initials: P
authors.lastname: Kiely
authors.forename: Ailsa
authors.initials: A
authors.lastname: Bosworth
authors.forename: Jo
authors.initials: J
authors.lastname: Ledingham
authors.forename: Andrew
authors.initials: A
authors.lastname: Ostör
authors.forename: Kate
authors.initials: K
authors.lastname: Gadsby
authors.forename: Frank
authors.initials: F
authors.lastname: McKenna
authors.forename: Diana
authors.initials: D
authors.lastname: Finney
authors.forename: Josh
authors.initials: J
authors.lastname: Dixey
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D000069283:Rituximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab; D008727:Methotrexate